Overview
Holt-Oram syndrome (HOS), also known as heart-hand syndrome or atriodigital dysplasia, is a rare genetic disorder characterized by upper limb skeletal abnormalities and congenital heart defects. It is caused by mutations in the TBX5 gene located on chromosome 12q24.1, which encodes a transcription factor critical for the development of the heart and upper limbs during embryonic growth. The condition affects both the musculoskeletal and cardiovascular systems, with highly variable expressivity even within the same family. Upper limb abnormalities are present in all affected individuals and range from subtle changes such as a triphalangeal or absent thumb, to more severe malformations including hypoplasia or absence of the radius, and phocomelia. These skeletal anomalies are typically bilateral but often asymmetric, with the left side more severely affected than the right. Congenital heart defects occur in approximately 75% of patients, most commonly ostium secundum atrial septal defects (ASD) and ventricular septal defects (VSD). Cardiac conduction abnormalities, including atrioventricular block and atrial fibrillation, may also occur and can be progressive, sometimes developing even in the absence of structural heart defects. There is no cure for Holt-Oram syndrome, and management is directed at the specific manifestations in each individual. Cardiac defects may require surgical repair or catheter-based intervention, and patients with conduction abnormalities may need pacemaker implantation. Orthopedic interventions, including surgery or prosthetics, may be considered for significant upper limb malformations. Regular cardiac monitoring, including electrocardiography and echocardiography, is recommended throughout life due to the risk of progressive conduction disease. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern and the 50% recurrence risk for offspring of an affected individual.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsJohns Hopkins University — NA
National Institute of Environmental Health Sciences (NIEHS)
National Heart, Lung, and Blood Institute (NHLBI)
Medical University of Vienna — NA
Unity Health Toronto — NA
Jean Seely — NA
Beth Israel Deaconess Medical Center
Centre Hospitalier Universitaire de Nīmes — NA
San Diego Veterans Healthcare System — NA
LifeBridge Health
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Holt-Oram syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Holt-Oram syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Holt-Oram syndrome.
Community
No community posts yet. Be the first to share your experience with Holt-Oram syndrome.
Start the conversation →Latest news about Holt-Oram syndrome
Disease timeline:
New recruiting trial: Gestational Diabetes After Gastric Bypass Surgery
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Development of 3T Magnetic Resonance Research Methods for NIA Studies
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Natural History of Advanced Chronic Liver Diseases
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Natural History Study of Kaposi Sarcoma
A new clinical trial is recruiting patients for Holt-Oram syndrome
New recruiting trial: Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
A new clinical trial is recruiting patients for Holt-Oram syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Holt-Oram syndrome
What is Holt-Oram syndrome?
Holt-Oram syndrome (HOS), also known as heart-hand syndrome or atriodigital dysplasia, is a rare genetic disorder characterized by upper limb skeletal abnormalities and congenital heart defects. It is caused by mutations in the TBX5 gene located on chromosome 12q24.1, which encodes a transcription factor critical for the development of the heart and upper limbs during embryonic growth. The condition affects both the musculoskeletal and cardiovascular systems, with highly variable expressivity even within the same family. Upper limb abnormalities are present in all affected individuals and ran
How is Holt-Oram syndrome inherited?
Holt-Oram syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Holt-Oram syndrome typically begin?
Typical onset of Holt-Oram syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Holt-Oram syndrome?
22 specialists and care centers treating Holt-Oram syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.